Epilepsy diagnosis after Covid-19: A population-wide study

Area of Science:

• Neurology
• Infectious Diseases
• Epidemiology

Background:

• Investigating the potential link between SARS-CoV-2 infection and new-onset epilepsy.
• Assessing the neurological sequelae of COVID-19.

Purpose of the Study:

• To determine if SARS-CoV-2 infection is associated with an increased risk of developing epilepsy.
• To analyze this association across different age groups and adjust for confounding factors.

Main Methods:

• A national register-based matched cohort study in Sweden.
• Utilized data from communicable disease surveillance (SmiNet) and patient/death registers.
• Employed Cox proportional hazards models for statistical analysis.

Main Results:

• No overall increased risk of epilepsy in the general population following SARS-CoV-2 infection (HR 1.01).
• A moderately increased risk was observed in patients aged 61-80 and 81-100 years.
• Risk remained significant in older age groups after adjusting for stroke, TBI, and tumors, but not always after including mechanical ventilation.

Conclusions:

• SARS-CoV-2 infection is not linked to a higher epilepsy risk at the population level.
• A slightly elevated risk was noted in individuals over 60 years old.
• The virus-induced epileptogenic effect is considered very small due to potential biases and ICU patient data.